Increased expression of phosphor AKT has been reported in preneoplastic lesions such as bronchial dysplasia, suggesting that AKT activation can be an early event in tumor progression and, thus, may represent a potentially important target for chemoprevention in individuals with high risk of lung cancer [59, 60]. This evidence concerns the gene AKT1 and neoplasm.